Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Baxter International (NY: BAX )

34.55 +0.14 (+0.41%)
Official Closing Price Updated: 7:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Baxter International

< Previous 1 2 3 4 5 6 7 8 9 Next >
Baxter (BAX): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Baxter’s stock price fell to $36.42. Shareholders have lost 7.3% of their capital, which is disappointing considering the S&P 500 has climbed by 1.5%. This might have... 
Via StockStory
Topics Stocks
Exposures US Equities
DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
What To Expect From CooperCompanies’s (COO) Q4 Earnings
Medical device company CooperCompanies (NASDAQ:COO) will be reporting results tomorrow after market close. Here’s what you need to know. 
Via StockStory
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified... 
Via StockStory
Demystifying Baxter Intl: Insights From 4 Analyst Reviews
Via Benzinga
Earnings Scheduled For February 20, 2025
Via Benzinga
Earnings Scheduled For February 13, 2025
Via Benzinga
How Is The Market Feeling About Baxter Intl?
Via Benzinga
Uncovering Potential: Baxter Intl's Earnings Preview
Via Benzinga
“From Left For Dead To Loved Again” Stock Market (and Sentiment Results)…
Healthcare is the top-performing sector in the market, up 7.31% and outperforming the S&P 500 by 4.2x. Looks like the rumors of its death were indeed GREATLY EXAGGERATED. 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4,... 
Via StockStory
Exploring the top movers within the S&P500 index during today's session.
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers. 
Via StockStory
3 Shareholder Yield Stocks For Growth And Dividends
Top shareholder yield stocks are generating returns by paying dividends, buying back stock, and reducing debt. 
Via Talk Markets
Uncover the latest developments among S&P500 stocks in today's session.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
What's going on in today's session: S&P500 movers
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook
Baxter International exceeded Q4 earnings and revenue estimates, with strong pharmaceutical sales. The company issued a mixed 2025 outlook amid cost pressures. 
Via Benzinga
Topics Earnings
Exposures Financial
Which S&P500 stocks are moving before the opening bell on Thursday?
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements. 
Via Chartmill
Baxter (NYSE:BAX) Beats Q4 Sales Targets, Stock Soars
Healthcare company Baxter International (NYSE:BAX) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $2.75 billion. On the other hand, next quarter’s revenue... 
Via StockStory
Baxter Earnings: What To Look For From BAX
Healthcare company Baxter International (NYSE:BAX) will be reporting earnings tomorrow morning. Here’s what investors should know. 
Via StockStory
What To Expect From Baxter’s (BAX) Q4 Earnings
Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow morning. Here’s what investors should know. 
Via StockStory
Deal Dispatch: PharmChem Forgoes Banker To Run Sale, TGI Fridays Sells 19 Restaurants For $3.1 Million
Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pursuing a deal for Fuji Soft. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Confidence Is Just As Dangerous When It's Too Low As When It's Too High
To attain goals, you need confidence. It takes self-assurance to pursue what matters most to you. But too much confidence has risks, too. 
Via Investor's Business Daily
Puerto Rico Blackout: 8 Stocks Affected By Island-Wide Power Outage
Only around 12% of Puerto Rico's residents currently have electricity, according to Luma Energy, the power company servicing the island. 
Via Benzinga
“Healthcare Left For Dead” Stock Market (And Sentiment Results)
This afternoon felt like either a fund blew up or the margin clerks were taking a bunch of dumb over-leveraged money out to the woodshed to put them out of their misery. 
Via Talk Markets
Topics Stocks / Equities
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
Baxter International: Dividend Cut Because Of Restructuring
Baxter International (BAX) cut its dividend because of the upcoming sale of the Kidney Care business, high debt and leverage, lower earnings per share, and free cash flow. 
Via Talk Markets
Topics Stocks / Equities
Baxter Expects Hurricane Helene Aftermath To Impact Near-Term Financial Outlook
Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and improved supply chain management. 
Via Benzinga
Topics Economy
Exposures Supply Chain
US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene
The U.S. faces a critical shortage of IV fluids due to Hurricane Helene's damage to Baxter's North Carolina plant, forcing hospitals to delay surgeries. Federal efforts to rebuild and import supplies... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.